Clinical Trials Browser

Metastatic Pancreatic Ductal Adenocarcinoma

Pancreatic Neoplasms, Neoplasms, Basal Cell

Breast Neoplasms, Inflammatory Breast Neoplasms

Neoplasm Metastasis

Fallopian Tube Neoplasms

Pancreatic Neoplasms

Cervical Adenocarcinoma

Stomach Neoplasms

Fallopian Tube Neoplasms

Breast Neoplasms, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

Urinary Bladder Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

Triple Negative Breast Neoplasms

Pancreatic Neoplasms

Breast Neoplasms

Adenocarcinoma Of Esophagus

Pancreatic Neoplasms

Pancreatic Neoplasms

Locally Advanced or Metastatic Solid Tumors

Pancreatic Neoplasms

Advanced Breast Cancer

Biliary Tract Neoplasms, Pancreatic Neoplasms

Pancreatic Neoplasms

Neoplasms, Pancreatic Neoplasms

Neoplasms, Pancreatic Neoplasms

Neoplasms, Pancreatic Neoplasms

Ovarian Neoplasms, Recurrence, Uterine Neoplasms

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Breast Neoplasms, Male

Carcinoma, Non-Small-Cell Lung

Gastric Adenocarcinoma

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Clinical Trials

ONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma

PANGEA

Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer

Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid Tumors

Matched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontline Ovarian Cancer (N-Dur)

Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer

External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer

Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery

Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer

Intravesicular Abraxane for Treatment-Refractory Bladder Cancer

Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer

Surufatinib Combined With KN046 and AG Regimen Chemotherapy as First-Line Treatment for Unresectable Advanced Pancreatic Cancer

FD-IMPACT

Paclitaxel and Ganetespib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Ipatasertib in Combination With Carboplatin, Carboplatin/Paclitaxel, or Capecitabine/Atezolizumab in Treating Patients With Metastatic Triple Negative Breast Cancer

Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer

Phase I/II Study of Weekly Abraxane and RAD001 in Women With Locally Adv. or Metastatic Breast Ca

Taladegib, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Localized Esophageal or Gastroesophageal Junction Cancer

BATS With in Combination With Low Dose IL-1 and GM-CSF for Advanced Pancreatic Cancer

Study of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas Cancer

IFNα Expressing Mesenchymal Stromal Cells for Locally Advanced/Metastatic Solid Tumors

AA NABPLAGEM

POLTER

An Open-label, Phase I/II Study of PLENA Regimen in Patients With Unresectable Pancreatic Cancer or BTC

MATRIX

High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer

High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer

High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer

Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer

Abraxane and Alimta in Advanced Solid Tumors

Vorinostat, Paclitaxel, and Radiation Therapy in Treating Patients Unable to Tolerate Cisplatin With Stage III Non-Small Lung Cancer That Cannot Be Removed By Surgery

Trial of ABI-007 Plus S-1 as Second-line Chemotherapy in Advanced Gastric Cancer Patients

Ph I/II Nab-Paclitaxel & Carboplatin w/Concurrent Radiation Therapy for Unresectable Stg III NSCLC